Logo image of PGN.DE

PARAGON GMBH & CO KGAA (PGN.DE) Stock Fundamental Analysis

Europe - FRA:PGN - DE0005558696 - Common Stock

2.7 EUR
+0.05 (+1.89%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, PGN scores 3 out of 10 in our fundamental rating. PGN was compared to 29 industry peers in the Automobile Components industry. PGN may be in some trouble as it scores bad on both profitability and health. PGN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year PGN has reported negative net income.
In the past year PGN had a positive cash flow from operations.
PGN had negative earnings in each of the past 5 years.
Of the past 5 years PGN 4 years had a positive operating cash flow.
PGN.DE Yearly Net Income VS EBIT VS OCF VS FCFPGN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.02%, PGN is doing worse than 89.66% of the companies in the same industry.
The Return On Invested Capital of PGN (14.50%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA -5.02%
ROE N/A
ROIC 14.5%
ROA(3y)-4.05%
ROA(5y)-6.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PGN.DE Yearly ROA, ROE, ROICPGN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

With a decent Operating Margin value of 5.73%, PGN is doing good in the industry, outperforming 62.07% of the companies in the same industry.
PGN has a Gross Margin of 53.77%. This is in the better half of the industry: PGN outperforms 79.31% of its industry peers.
PGN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.73%
PM (TTM) N/A
GM 53.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.83%
GM growth 5Y0.61%
PGN.DE Yearly Profit, Operating, Gross MarginsPGN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PGN is creating value.
The number of shares outstanding for PGN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, PGN has about the same amount of shares outstanding.
The debt/assets ratio for PGN is higher compared to a year ago.
PGN.DE Yearly Shares OutstandingPGN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
PGN.DE Yearly Total Debt VS Total AssetsPGN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

PGN has an Altman-Z score of 0.65. This is a bad value and indicates that PGN is not financially healthy and even has some risk of bankruptcy.
PGN's Altman-Z score of 0.65 is on the low side compared to the rest of the industry. PGN is outperformed by 93.10% of its industry peers.
PGN has a debt to FCF ratio of 17.07. This is a negative value and a sign of low solvency as PGN would need 17.07 years to pay back of all of its debts.
PGN has a worse Debt to FCF ratio (17.07) than 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 17.07
Altman-Z 0.65
ROIC/WACC1.85
WACC7.86%
PGN.DE Yearly LT Debt VS Equity VS FCFPGN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

PGN has a Current Ratio of 0.57. This is a bad value and indicates that PGN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.57, PGN is doing worse than 96.55% of the companies in the same industry.
PGN has a Quick Ratio of 0.57. This is a bad value and indicates that PGN is not financially healthy enough and could expect problems in meeting its short term obligations.
PGN has a worse Quick ratio (0.32) than 96.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.32
PGN.DE Yearly Current Assets VS Current LiabilitesPGN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

PGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.25%, which is quite impressive.
Looking at the last year, PGN shows a very negative growth in Revenue. The Revenue has decreased by -22.97% in the last year.
The Revenue has been decreasing by -6.72% on average over the past years.
EPS 1Y (TTM)20.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.01%
Revenue 1Y (TTM)-22.97%
Revenue growth 3Y0.07%
Revenue growth 5Y-6.72%
Sales Q2Q%-24.23%

3.2 Future

Based on estimates for the next years, PGN will show a very strong growth in Earnings Per Share. The EPS will grow by 84.82% on average per year.
PGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.78% yearly.
EPS Next Y172.17%
EPS Next 2Y96.49%
EPS Next 3Y84.82%
EPS Next 5YN/A
Revenue Next Year4.99%
Revenue Next 2Y4.51%
Revenue Next 3Y5.78%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PGN.DE Yearly Revenue VS EstimatesPGN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
PGN.DE Yearly EPS VS EstimatesPGN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 0 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PGN. In the last year negative earnings were reported.
PGN is valuated correctly with a Price/Forward Earnings ratio of 12.49.
Based on the Price/Forward Earnings ratio, PGN is valued a bit more expensive than the industry average as 68.97% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, PGN is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.49
PGN.DE Price Earnings VS Forward Price EarningsPGN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PGN is valued a bit cheaper than the industry average as 72.41% of the companies are valued more expensively.
86.21% of the companies in the same industry are more expensive than PGN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.05
EV/EBITDA 2.91
PGN.DE Per share dataPGN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PGN's earnings are expected to grow with 84.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y96.49%
EPS Next 3Y84.82%

0

5. Dividend

5.1 Amount

No dividends for PGN!.
Industry RankSector Rank
Dividend Yield N/A

PARAGON GMBH & CO KGAA

FRA:PGN (9/15/2025, 7:00:00 PM)

2.7

+0.05 (+1.89%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-19 2025-08-19
Earnings (Next)11-12 2025-11-12
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners50%
Ins Owner ChangeN/A
Market Cap12.23M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)66%
EPS NY rev (3m)66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.49
P/S 0.11
P/FCF 3.05
P/OCF 0.8
P/B N/A
P/tB N/A
EV/EBITDA 2.91
EPS(TTM)-1.12
EYN/A
EPS(NY)0.22
Fwd EY8.01%
FCF(TTM)0.89
FCFY32.83%
OCF(TTM)3.37
OCFY124.78%
SpS25.57
BVpS-1.74
TBVpS-9.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.02%
ROE N/A
ROCE 20.6%
ROIC 14.5%
ROICexc 20.71%
ROICexgc N/A
OM 5.73%
PM (TTM) N/A
GM 53.77%
FCFM 3.47%
ROA(3y)-4.05%
ROA(5y)-6.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.83%
GM growth 5Y0.61%
F-Score6
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 17.07
Debt/EBITDA 1.68
Cap/Depr 71.79%
Cap/Sales 9.71%
Interest Coverage 1.03
Cash Conversion 68.44%
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.32
Altman-Z 0.65
F-Score6
WACC7.86%
ROIC/WACC1.85
Cap/Depr(3y)54.54%
Cap/Depr(5y)64.78%
Cap/Sales(3y)5.81%
Cap/Sales(5y)7.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.01%
EPS Next Y172.17%
EPS Next 2Y96.49%
EPS Next 3Y84.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.97%
Revenue growth 3Y0.07%
Revenue growth 5Y-6.72%
Sales Q2Q%-24.23%
Revenue Next Year4.99%
Revenue Next 2Y4.51%
Revenue Next 3Y5.78%
Revenue Next 5YN/A
EBIT growth 1Y228.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y165.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y565.87%
OCF growth 3Y6.93%
OCF growth 5YN/A